CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Congenital Abnormalities D000013 11 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Anemia D000740 21 associated lipids
Arteriosclerosis D001161 86 associated lipids
Asthma D001249 52 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Birth Weight D001724 23 associated lipids
Body Weight D001835 333 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Carcinoma 256, Walker D002279 22 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Chancroid D002602 4 associated lipids
Chondrosarcoma D002813 9 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Erythroblastosis, Fetal D004899 2 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Eye Diseases D005128 12 associated lipids
Factor XII Deficiency D005175 2 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Galactosemias D005693 5 associated lipids
Glioma D005910 112 associated lipids
Granulomatous Disease, Chronic D006105 4 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hyperinsulinism D006946 27 associated lipids
Hypertension D006973 115 associated lipids
Hypoglycemia D007003 13 associated lipids
Infectious Mononucleosis D007244 5 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Insulinoma D007340 28 associated lipids
Adenoma, Islet Cell D007516 7 associated lipids
Kidney Diseases D007674 29 associated lipids
Leukemia D007938 74 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lymphoma D008223 18 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Medulloblastoma D008527 22 associated lipids
Melanoma D008545 69 associated lipids
Neutropenia D009503 15 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Pharyngeal Neoplasms D010610 4 associated lipids
Pituitary Neoplasms D010911 4 associated lipids
Starvation D013217 47 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thymus Neoplasms D013953 15 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Trisomy D014314 6 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Wiskott-Aldrich Syndrome D014923 3 associated lipids
Wounds and Injuries D014947 20 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
CREST Syndrome D017675 2 associated lipids
Glucose Intolerance D018149 13 associated lipids
Coronavirus Infections D018352 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Fenech M et al. Preliminary studies on scoring micronuclei by computerised image analysis. 1988 Mutat. Res. pmid:3340091
Parry JM and Kirsch-Volders M Special issue on in vitro MN trial. 2010 Mutat. Res. pmid:20654729
Kirkland D Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): summary of results in the collaborative trial. 2010 Mutat. Res. pmid:20149894
Kirkland D Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): introduction to the collaborative trial. 2010 Mutat. Res. pmid:20176128
Surrallés J and Natarajan AT Human lymphocytes micronucleus assay in Europe. An international survey. 1997 Mutat. Res. pmid:9269340
Lindholm C et al. Induction of micronuclei and anaphase aberrations by cytochalasin B in human lymphocyte cultures. 1991 Mutat. Res. pmid:1870625
Dimitrijević A et al. Micronucleus frequency in women with genital Chlamydia Trachomatis infection before and after therapy. 2006 Mutat. Res. pmid:16777475
Erexson GL et al. Diaziquone-induced micronuclei in cytochalasin B-blocked mouse peripheral blood lymphocytes. 1987 Mutat. Res. pmid:3574322
Leach NT and Jackson-Cook C The application of spectral karyotyping (SKY) and fluorescent in situ hybridization (FISH) technology to determine the chromosomal content(s) of micronuclei. 2001 Mutat. Res. pmid:11448638
Scarfì MR et al. Measurement of micronuclei by cytokinesis-block method in bovine lymphocytes. 1993 Mutat. Res. pmid:7690898
Streffer C et al. Micronuclei-biological indicator for retrospective dosimetry after exposure to ionizing radiation. 1998 Mutat. Res. pmid:9729308
Wakata A and Sasaki MS Measurement of micronuclei by cytokinesis-block method in cultured Chinese hamster cells: comparison with types and rates of chromosome aberrations. 1987 Mutat. Res. pmid:3099194
Santos-Mello R et al. Induction of micronuclei by alkaloids extracted from Senecio brasiliensis and stored for 23 years. 2002 Mutat. Res. pmid:11943607
Garriott ML et al. A protocol for the in vitro micronucleus test. I. Contributions to the development of a protocol suitable for regulatory submissions from an examination of 16 chemicals with different mechanisms of action and different levels of activity. 2002 Mutat. Res. pmid:12034314
Aardema MJ et al. SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells. 2006 Mutat. Res. pmid:16797224
Fucić A et al. X-rays, microwaves and vinyl chloride monomer: their clastogenic and aneugenic activity, using the micronucleus assay on human lymphocytes. 1992 Mutat. Res. pmid:1379689
Curren RD et al. Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). 2006 Mutat. Res. pmid:16781186
Wakata A et al. SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells. 2006 Mutat. Res. pmid:16782396
Lorge E et al. SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study. 2006 Mutat. Res. pmid:16815079
Fenech M Commentary on the SFTG international collaborative study on the in vitro micronucleus test: to Cyt-B or not to Cyt-B? 2006 Mutat. Res. pmid:16720100
Whong WZ et al. Use of rat primary lung cells for studying genotoxicity with the sister-chromatid exchange and micronucleus assays. 1990 Mutat. Res. pmid:2333086
Uma Devi P et al. A method to score micronuclei in vivo using cytochalasin B-induced cytokinesis block. 1998 Mutat. Res. pmid:9639669
Fellows MD et al. Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. II: Practical aspects with toxic agents. 2008 Aug-Sep Mutat. Res. pmid:18602493
Lorge E et al. Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. I. Theoretical aspects. 2008 Aug-Sep Mutat. Res. pmid:18602494
Mudry MD et al. Mutagenic bioassay of certain pharmacological drugs: III. Metronidazole (MTZ). 1994 Mutat. Res. pmid:7510021
Poma A et al. Inhibition of L-tyrosine-induced micronuclei production by phenylthiourea in human melanoma cells. 1999 Mutat. Res. pmid:10635335
Santos-Mello R et al. Induction of micronuclei by CsCl in vivo and in vitro. 1999 Mutat. Res. pmid:10635347
Fenech M and Morley AA Measurement of micronuclei in lymphocytes. 1985 Feb-Apr Mutat. Res. pmid:3974610
Nefic H and Handzic I The effect of age, sex, and lifestyle factors on micronucleus frequency in peripheral blood lymphocytes of the Bosnian population. 2013 Mutat. Res. pmid:23499242
Schaude M et al. In vitro effect of terbinafine on human leukocyte chemotaxis and chemiluminescence. 1988 Mycoses pmid:3419453
Weissmann G et al. Release of inflammatory mediators from stimulated neutrophils. 1980 N. Engl. J. Med. pmid:6246431
De Vivo DC et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. 1991 N. Engl. J. Med. pmid:1714544
Wei M et al. [Screening differentially expressed genes in denucleated K562 cells with restriction display technique]. 2006 Nan Fang Yi Ke Da Xue Xue Bao pmid:16503519
Sokolov I et al. Recovery of elasticity of aged human epithelial cells in vitro. 2006 Nanomedicine pmid:17292113
Dreifuss T et al. Uptake mechanism of metabolic-targeted gold nanoparticles. 2018 Nanomedicine (Lond) pmid:30028251
Hacke M et al. Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol. 2015 Nat Commun pmid:26158910
Wu T et al. Spindle tubulin and MTOC asymmetries may explain meiotic drive in oocytes. 2018 Nat Commun pmid:30054463
Burnette DT et al. Filopodial actin bundles are not necessary for microtubule advance into the peripheral domain of Aplysia neuronal growth cones. 2007 Nat. Cell Biol. pmid:18026092
Medjkane S et al. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. 2009 Nat. Cell Biol. pmid:19198601
Sáenz JB et al. Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. 2009 Nat. Chem. Biol. pmid:19182783
Kole MH et al. Action potential generation requires a high sodium channel density in the axon initial segment. 2008 Nat. Neurosci. pmid:18204443
Sundqvist KG and Otteskog P Cytochalasin B induces polarisation of plasma membrane components aand actin in transformed cells. 1978 Nature pmid:210398
Nicklas WJ and Berl S Effects of cytochalasin B on uptake and release of putative transmitters by synaptosomes and on brain actomyosin-like protein. 1974 Nature pmid:4150454
Diamond RD Antibody-dependent killing of Cryptococcus neopormans by human peripheral blood mononuclear cells. 1974 Nature pmid:4589453
Johnson MH et al. Mosaicism in organisation concanavalin A receptors on surface membrane of mouse egg. 1975 Nature pmid:1172195
Faulk WP et al. Immunobiology of membrane-bound collagen on mouse fibroblasts. 1975 Nature pmid:1097933
Sethi KK and Brandis H Introduction of mouse L cell nucleus into heterologous mammalian cells. 1974 Nature pmid:4368841
Bentley D and Toroian-Raymond A Disoriented pathfinding by pioneer neurone growth cones deprived of filopodia by cytochalasin treatment. 1986 Oct 23-29 Nature pmid:3773996
Cooper HL and Braverman R The mechanism by which actinomycin D inhibits protein synthesis in animal cells. 1977 Nature pmid:909606
Fukuda J et al. Breakdown of cytoskeletal filaments selectively reduces Na and Ca spikes in cultured mammal neurones. 1981 Nature pmid:7197327